Using a peak flow meter to assess severity of exacerbation in patients suffering from chronic obstructive pulmonary disease: a prospective observational study

Arunkumar Sreekumar; Kiran Kumar

doi:10.18203/2320-6012.ijrms20231036

Authors

Arunkumar Sreekumar Department of Medicine, Amrita Institute of Medical Sciences, Kochi, Kerala, India https://orcid.org/0000-0003-3425-0350
Kiran Kumar Department of Community Medicine, Government Medical College, Surat, Gujarat, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20231036

Keywords:

PEFR, COPD, Exacerbation, Peak flow, Peak flowmeter, SpO2

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is an important and dangerous public health concern, and deaths due to it has become the leading cause of mortality in several countries. Exacerbations of the disease are very common and is frequently responsible for progressive decline in lung function, quality of life and ultimately death. Through this study, we hypothesize whether estimating peak expiratory flow rate (PEFR) using a simple peak flowmeter could help in early prediction of the intensity and severity of exacerbations of COPD.

Methods: This study was conducted amongst 100 patients, at Amrita Institute of Medical Sciences, Kochi, Kerala, who were diagnosed with COPD, based on GOLD criteria and respective pulmonary function tests. Their PEFR and oxygen saturation values were recorded during their routine clinic visits and during an exacerbation episode and results were analyzed.

Results: Out of 100 patients, 91 were males and 9 were female patients, with a mean age of 64.4 years and commonest age affected is 55 years. Average duration of COPD amongst the study participants ranged from 4 to 11 years with a mean of 7.19 years. PEFR was graded into 3 zones based on guidelines and measurements noted. Of the 76 male patients with 80-100% PEFR recordings, 10 (13.15%) had a drop to 50-80% PEFR and 66 (86.85%) of them dropped to <50% PEFR reading during an exacerbation. For the female subjects, of the 9 patients with 80-100% of expected PEFR, 3 (33.33%) had dropped to 50-80% and 6 (66.69%) had dropped to <50% of PEFR reading. SpO2 had significant change at exacerbations as compared during normal phase dropping with mean of 94.82 to 81.3 which was statistically significant across age and gender. Wilcoxon signed rank test was done to quantify statistical change showed z score of -9.138 with p<0.0001, which was significant across age and gender groups.

Conclusions: As a simple, inexpensive tool, peak flowmeter could be useful for bedside monitoring of severity of exacerbation of COPD. This could be vital for early detection and appropriate medical intervention.

Metrics

Metrics Loading ...

References

Wilkinson TMA, Donladson GC, Hurst JR. Early therapy improves outcome of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169:1298-303.

Kelly CA, Gibson GJ. Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax. 1988;43(4):335-6.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Revised 2014. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available at: www.goldcopd.org. Accessed on 25 January 2023.

Langsetmo L, Platt RW, Ernst P. Underreporting Exacerbation of Chronic Obstructive Pulmonary Disease in a Longitudinal Cohort. Am J Respir Crit Care Med. 2008;177(4):396-401.

Jain P, Kavuru MS, Emerman CL. Utility of peak expiratory flow monitoring. Chest. 1998;114(3):861-76.

Donaldson GC, Seemungal TA, Bhowmik A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847-52.

So JY, Lastra AC, Zhao H, Marchetti N, Criner GJ. Daily peak expiratory flow rate and disease instability in chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2016;3(1):398-405.

Murata G, Glium DJ, Busby HK. Precision and accuracy of self-measured peak expiratory flow rates in chronic obstructive pulmonary disease. South Med J. 1998;91(10):919-24.

Murata GH, Kapsner CO, Lium DJ. Patient compliance with peak flow monitoring in chronic obstructive pulmonary disease. Am J Med Sci. 1998;315(5):296-301.

Jackson H, Hubbard R. Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey. BMJ. 2003;327(7416):653-4.

American Lung Association; Interpreting the PEFR. Available at: https://www.lung.org/lung-health-diseases/lung-disease-lookup/asthma/treatment/ devices/peak-flow. Accessed on 22 January 2023.

Ramsdale EH, Morris MM, Hargreave FE. Interpretation of the variability of peak flow rates in chronic bronchitis. Thorax. 1986;41(10):771-6.

Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925-31.

Perez-Padilla R, Vollmer WM, Vázquez-García JC, Enright PL, Menezes AM, Buist AS, et al. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis. 2009;13(3):387-93.